Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HAL vs GSK✓SelectedUSD · GSKHAL vs GSK performance historyLatest closeAs of-3.78%11/20
Stock and ETF performance explorer

HAL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+21.6%
GSK return
+6.1%
Excess return
+15.4%
Maximum drawdown
-28.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.8%-0.1%-3.7%-3.8%
7D-9.6%-5.3%-4.3%-10.0%
30D-10.2%-3.7%-6.5%-10.4%
3M-14.1%-7.3%-6.8%-14.3%
6M-27.2%-4.2%-22.9%-27.3%
YTD+9.5%+0.9%+8.7%+8.8%
1Y+21.6%+7.3%+14.3%+19.5%
All+21.6%+6.1%+15.4%+19.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling